You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Refractory Acute Lymphocytic Leukemia

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Ghent, Belgium
  • +28 more
Nov 11, 2022

Relapsed/Refractory Large Granular T Lymphocytic Leukemia Trial in Zhoukou, Tianjin (Linperlisib)

Not yet recruiting
  • Relapsed/Refractory Large Granular T Lymphocytic Leukemia
  • Zhoukou, Henan, China
  • +1 more
Dec 22, 2022

Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

Not yet recruiting
  • Recurrent Chronic Lymphocytic Leukemia
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Acute Lymphocytic Leukemia, Diffuse Large Cell Lymphoma Trial in Philadelphia (huCART19)

Completed
  • Acute Lymphocytic Leukemia
  • Diffuse Large Cell Lymphoma
  • huCART19
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Sep 22, 2021

Acute Lymphocytic Leukemia, B-Cell Trial in Taiyuan (CD19-CD22 CAR-T cells)

Recruiting
  • Acute Lymphocytic Leukemia， B-Cell
  • CD19-CD22 CAR-T cells
  • Taiyuan, Shanxi, China
    Hematology Department of ShanXi Cancer Hospital
Jan 17, 2021

CD22 Positive, Recurrent Acute Lymphoblastic Leukemia, Refractory Acute Lymphoblastic Leukemia Trial in Houston (Inotuzumab

Terminated
Has Results
  • CD22 Positive
  • +2 more
  • Inotuzumab Ozogamicin
  • Houston, Texas
    M D Anderson Cancer Center
Mar 17, 2021

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

Not yet recruiting
  • Myeloid Malignancies
  • +3 more
  • (no location specified)
Mar 22, 2023

B-cell Acute Lymphocytic Leukemia Trial in Suzhou (CD19 CAR-T cells)

Recruiting
  • B-cell Acute Lymphocytic Leukemia
  • CD19 CAR-T cells
  • Suzhou, China
    The First Affiliated Hospital of Soochow University
Jan 11, 2023

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, in Relapse
  • anti Tim-3/CD123 CAR-T cell therapy
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 4, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 20, 2023

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

Leukemia, Lymphoma, Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial (BGB-11417)

Not yet recruiting
  • Leukemia
  • +4 more
  • (no location specified)
Jul 27, 2022

Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +6 more
  • (no location specified)
Apr 12, 2023

Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

Not yet recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • Acute Lymphoblastic Leukemia With Failed Remission
  • São Paulo, SP, Brazil
    Instituto do Cancer do Estado de Sao Paulo
Sep 12, 2023

BESPONSA Injection 1 mg Special Investigation

Active, not recruiting
  • Acute Lymphocytic Leukemia
    • Tokyo, Japan
      Pfizer
    Jun 20, 2023

    Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 23, 2023

    Acute Lymphocytic Leukemia Trial in Langfang (Autologous CD19-targeting CAR T cells)

    Unknown status
    • Acute Lymphocytic Leukemia
    • Autologous CD19-targeting CAR T cells
    • Langfang, Hebei, China
      Hebei Yanda Ludaopei Hospital
    Jan 18, 2021

    ALL, Adult, AML, Adult Trial (BN104)

    Not yet recruiting
    • ALL, Adult
    • AML, Adult
    • (no location specified)
    Sep 19, 2023

    Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Lyon, France
      Centre Léon Bérard
    Nov 30, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023